{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:27:41Z","timestamp":1771932461005,"version":"3.50.1"},"reference-count":68,"publisher":"American Academy of Insurance Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Insur Med"],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:p>Lung cancer is the most common cause of cancer-related mortality worldwide. With the introduction of low-dose computed tomography (LDCT), detection of adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA) are increasingly being found in young, never-smoking females in Asia. There are survival studies suggesting that these early cancers, with resection, have no recurrence in 5 and even 10 years and therefore might be considered cured, allowing for favorable underwriting consideration for life insurance. However, other studies have shown incidences of secondary primary lung cancers (SPLCs) occurring within 10 years after surgical resections of AIS and MIA tumors, but with their clinical course and response to treatment appear to be better than original primary lung cancers, potentially still allowing for insurance with rating. The goal of this article is to review the evidence both for and against insuring these populations of lung cancer patients.<\/jats:p>","DOI":"10.17849\/insm-53-1-1-7.2","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:51:37Z","timestamp":1770771097000},"page":"98-104","source":"Crossref","is-referenced-by-count":0,"title":["Are There Types of Early-Stage Adenocarcinomas That Are Insurable?"],"prefix":"10.17849","volume":"53","author":[{"given":"Wei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7324","reference":[{"key":"i-53-1-98-ref01","series-title":"J Thorac Dis","first-page":"S526","article-title":"The new IASLC\/ATS\/ERS lung adenocarcinoma classification from a clinical perspective: current concepts and future prospects","volume":"6","author":"Zugazagoitia","year":"2014","unstructured":"Zugazagoitia J,\nEnguita AB,\nNu\u00f1ez JA,\nIglesias L,\nPonce S. The new IASLC\/ATS\/ERS lung adenocarcinoma classification from a clinical perspective: current concepts and future prospects. J Thorac Dis. 2014;6:S526\u2013S536. doi: 10.3978\/j.issn.2072-1439.2014.01.27"},{"key":"i-53-1-98-ref02","article-title":"Adenocarcinoma in situ, minimally invasive adenocarcinoma and invasive adenocarcinoma of lung","author":"Kusel","unstructured":"Kusel K. Adenocarcinoma in situ, minimally invasive adenocarcinoma and invasive adenocarcinoma of lung. Last revised on 8 Mar 2022. Radiology Reference Article | Radiopaedia.org."},{"key":"i-53-1-98-ref03","series-title":"Insights into Imaging","first-page":"69","article-title":"Adenocarcinoma of the lung: from BAC to the future","volume":"11","author":"Lambe","year":"2020","unstructured":"Lambe G,\nDurand M,\nBuckley A,\nNicholson S,\nMcDermott R. Adenocarcinoma of the lung: from BAC to the future. Insights into Imaging. 2020;11:69. doi: 10.1186\/s13244-020-00875-6"},{"key":"i-53-1-98-ref04","series-title":"J Thorac Oncol","first-page":"1204","article-title":"The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer","volume":"11","author":"Travis","year":"2016","unstructured":"Travis WD,\nAsamura H,\nBankier AA, et al. The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer. J Thorac Oncol. 2016;11:1204\u20131223."},{"key":"i-53-1-98-ref05","series-title":"J Clinical and Diagnostic Research","first-page":"EE01","article-title":"An Update on WHO Classification of Thoracic Tumours 2021- Newly Described Entities and Terminologies","volume":"17","author":"Singh","year":"2023","unstructured":"Singh G,\nSingh A,\nDAVE R. An Update on WHO Classification of Thoracic Tumours 2021- Newly Described Entities and Terminologies. J Clinical and Diagnostic Research. 2023;17:EE01\u2013EE05. doi: 10.7860\/JCDR\/2023\/62583.18076"},{"key":"i-53-1-98-ref06","series-title":"J National Cancer Center","first-page":"278","article-title":"The epidemiological landscape of lung cancer: current status, temporal trend and future projections based on the latest estimates from GLOBOCAN 2022","volume":"5","author":"Ji","year":"2025","unstructured":"Ji Y,\nZhang Y,\nLiu S, et al. The epidemiological landscape of lung cancer: current status, temporal trend and future projections based on the latest estimates from GLOBOCAN 2022. J National Cancer Center. 2025;5:278\u2013286."},{"key":"i-53-1-98-ref07","series-title":"The LANCET Respiratory Medicine","first-page":"348","article-title":"Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study","volume":"13","author":"Luo","year":"2025","unstructured":"Luo G,\nZhang Y,\nRumgay H, et al. Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study. The LANCET Respiratory Medicine. 2025;13:348\u2013363. doi: 10.1016\/S2213-2600(24)00428-4"},{"key":"i-53-1-98-ref08","series-title":"Frontiers in Oncology","first-page":"1059","article-title":"Epidemiology of Ground Glass Opacity Lung Adenocarcinoma: A Network-Based Cumulative Meta-Analysis","volume":"10","author":"Li","year":"2020","unstructured":"Li X,\nRen F,\nWang S, et al. Epidemiology of Ground Glass Opacity Lung Adenocarcinoma: A Network-Based Cumulative Meta-Analysis. Frontiers in Oncology. 2020;10:1059. doi: 10.3389\/fonc.2020.01059"},{"key":"i-53-1-98-ref09","series-title":"J Thorac Dis","first-page":"5383","article-title":"Discriminating invasive adenocarcinoma among lung pure ground-glass nodules: a multi-parameter prediction model","volume":"13","author":"Hu","year":"2021","unstructured":"Hu F,\nHuang H,\nJiang Y, et al. Discriminating invasive adenocarcinoma among lung pure ground-glass nodules: a multi-parameter prediction model. J Thorac Dis. 2021;13:5383\u20135394. doi: 10.21037\/jtd-21-786"},{"key":"i-53-1-98-ref10","series-title":"J Thorac Oncol","first-page":"77","article-title":"Screening for Lung Cancer, Overdiagnosis, and Healthcare Utilization: A Nationwide Population-Based Study","volume":"20","author":"Kim","year":"2025","unstructured":"Kim SY,\nSilvestri GA,\nKim YW, et al. Screening for Lung Cancer, Overdiagnosis, and Healthcare Utilization: A Nationwide Population-Based Study. J Thorac Oncol. 2025;20:77\u2013588. doi: 10.1016\/j.jtho.2024.12.006"},{"key":"i-53-1-98-ref11","series-title":"JAMA Internal Medicine","article-title":"Association of Computed Tomographic Screening Promotion With Lung Cancer Overdiagnosis Among Asian Women","author":"Gao","year":"2022","unstructured":"Gao W,\nWen CP,\nWu A,\nWelch HG. Association of Computed Tomographic Screening Promotion With Lung Cancer Overdiagnosis Among Asian Women. JAMA Internal Medicine. Published online January 18, 2022. doi: 10.1001\/jamainternmed.2021.7769"},{"key":"i-53-1-98-ref12","series-title":"Trans Lung Cancer Res","first-page":"452","article-title":"Lung cancer screening strategy for non-high-risk individuals: a narrative review","volume":"10","author":"Fu","year":"2021","unstructured":"Fu F,\nZhou Y,\nZhang Y,\nChen H. Lung cancer screening strategy for non-high-risk individuals: a narrative review. Trans Lung Cancer Res. 2021;10:452\u2013461. doi: 10.21037\/tlcr-20-943"},{"key":"i-53-1-98-ref13","series-title":"Chinese J Lung Cancer","first-page":"911","article-title":"Analysis of Clinical Epidemiological Characteristics of 15,967 Lung Cancer Surgery Patients in Yunnan Cancer Hospital from 2013 to 2022","volume":"27","author":"Tang","year":"2024","unstructured":"Tang R,\nLei Y,\nYe L, et al. Analysis of Clinical Epidemiological Characteristics of 15,967 Lung Cancer Surgery Patients in Yunnan Cancer Hospital from 2013 to 2022. Chinese J Lung Cancer. 2024;27:911. doi: 10.3779\/j.issn.1009-3419.2024.101.33"},{"key":"i-53-1-98-ref14","series-title":"Am J Respir Crit Care Med","first-page":"1208","article-title":"Recent trends in the identification of incidental pulmonary nodules","volume":"192","author":"Gould","year":"2015","unstructured":"Gould MK,\nTang T,\nLiu ILA, et al. Recent trends in the identification of incidental pulmonary nodules. Am J Respir Crit Care Med. 2015;192:1208. doi: 10.1164\/rccm.201505-0990OC"},{"key":"i-53-1-98-ref15","series-title":"European Radiology","first-page":"8279","article-title":"Trends in the incidence of pulmonary nodules in chest computed tomography","volume":"33","author":"Ward","year":"2023","unstructured":"Ward H,\nMatthieu R,\nNils H, et al. Trends in the incidence of pulmonary nodules in chest computed tomography. European Radiology. 2023;33:8279\u20138288. doi: 10.1007\/s00330-023-09826-3"},{"key":"i-53-1-98-ref16","series-title":"Scientific Reports","first-page":"13657","article-title":"Development and clinical application of deep learning model for lung nodules screening on CT images","volume":"10","author":"Gui","year":"2020","unstructured":"Gui S,\nMing S,\nLin Y, et al. Development and clinical application of deep learning model for lung nodules screening on CT images. Scientific Reports. 2020;10:13657. doi: 10.1038\/s41598-020-70629-3"},{"key":"i-53-1-98-ref17","series-title":"Respiration","first-page":"1024","article-title":"Incidental Pulmonary Nodules \u2013 What Do We Know in 2022","volume":"101","author":"Schmid-Bindert","year":"2022","unstructured":"Schmid-Bindert G,\nVogel-Claussen J,\nGutz S, et al. Incidental Pulmonary Nodules \u2013 What Do We Know in 2022. Respiration. 2022;101:1024\u20131034. doi: 10.1159\/000526818"},{"key":"i-53-1-98-ref18","series-title":"Cell Research","first-page":"649","article-title":"Treating lung cancer: defining surgical curative time window","volume":"33","author":"Fu","year":"2023","unstructured":"Fu F,\nChen Z,\nChen H. Treating lung cancer: defining surgical curative time window. Cell Research. 2023;33:649\u2013650. doi: 10.1038\/s41422-023-00852-w"},{"key":"i-53-1-98-ref19","series-title":"J Thorac Cardiovasc Surg","first-page":"456","article-title":"Surgery for pre- and minimally invasive lung adenocarcinoma","volume":"163","author":"Zhang","year":"2022","unstructured":"Zhang Y,\nMa X,\nShen X, et al. Surgery for pre- and minimally invasive lung adenocarcinoma. J Thorac Cardiovasc Surg. 2022;163:456\u2013464. doi: 10.1016\/j.jtcvs.2020.11.151"},{"key":"i-53-1-98-ref20","series-title":"J Thorac Cardiovasc Surg","first-page":"1614","article-title":"Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative","volume":"164","author":"Li","year":"2022","unstructured":"Li D,\nDeng C,\nWang S, et al. Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative. J Thorac Cardiovasc Surg. 2022;164:1614\u20131622. doi: 10.1016\/j.jtcvs.2022.06.017"},{"key":"i-53-1-98-ref21","series-title":"J Thorac Oncol","first-page":"1312","article-title":"Long-Term Prognosis of Patients with Resected Adenocarcinoma in situ and Minimally Invasive Adenocarcinoma of the Lung","volume":"16","author":"Yotsukura","year":"2021","unstructured":"Yotsukura M,\nAsamura H,\nMotoi N, et al. Long-Term Prognosis of Patients with Resected Adenocarcinoma in situ and Minimally Invasive Adenocarcinoma of the Lung. J Thorac Oncol. 2021;16:1312. doi: 10.1016\/j.jtho.2021.04.007. PMID: doi: 33915249"},{"key":"i-53-1-98-ref22","series-title":"J Thorac Cardiovasc Surg","first-page":"606","article-title":"Multiple primary lung cancers","volume":"70","author":"Martini","year":"1975","unstructured":"Martini N and Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70:606. PMID: doi: 170482"},{"key":"i-53-1-98-ref23","series-title":"Ann Thorac Surg","first-page":"863","article-title":"Second primary lung cancer","volume":"59","author":"Antakli","year":"1995","unstructured":"Antakli T,\nSchaefer RF,\nRutherford JE,\nRead RC. Second primary lung cancer. Ann Thorac Surg. 1995;59:863. doi: 10.1016\/0003-4975(95)00067-u. PMID: doi: 7695410"},{"key":"i-53-1-98-ref24","series-title":"J Thorac Oncol","first-page":"639","article-title":"The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification","volume":"11","author":"Detterbeck","year":"2016","unstructured":"Detterbeck FC,\nNicholson AG,\nFranklin WA, et al. The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification. J Thorac Oncol. 2016;11:639. doi: 10.1016\/j.jtho.2016.01.024. PMID: doi: 26940528"},{"key":"i-53-1-98-ref25","series-title":"Front Oncol","first-page":"1034752","article-title":"Multiple primary lung cancer: Updates of clinical management and genomic features","volume":"13","author":"Tian","year":"2023","unstructured":"Tian H,\nBai G,\nYang Z, et al. Multiple primary lung cancer: Updates of clinical management and genomic features. Front Oncol. 2023;13:1034752. doi: 10.33389\/fonc.2023.1034752. PMID: doi: 36910635"},{"key":"i-53-1-98-ref26","article-title":"Second Cancers After Lung Cancer","author":"The American Cancer Society medical and editorial content team","year":"2024","unstructured":"The American Cancer Society medical and editorial content team. Second Cancers After Lung Cancer. Last Revised: January 29, 2024. Cancer.org."},{"key":"i-53-1-98-ref27","series-title":"J Thorac Oncol","first-page":"1415","article-title":"Second Primary Lung Cancer \u2013 An Emerging Issue in Lung Cancer Survivors","volume":"19","author":"Jensen","year":"2024","unstructured":"Jensen S \u00d8,\nMoore DA,\nSurani AA,\nCrosbie PAJ,\nRosenfeld N,\nRintoul RC. Second Primary Lung Cancer \u2013 An Emerging Issue in Lung Cancer Survivors. J Thorac Oncol. 2024;19:1415\u20131426. doi: 10.1016\/j.jtho.2024.07.014"},{"key":"i-53-1-98-ref28","series-title":"J Clin Oncol","first-page":"2893","article-title":"Risk Stratification for Second Primary Lung Cancer","volume":"35","author":"Han","year":"2017","unstructured":"Han SS,\nRivera GA,\nTammemagi MC, et al. Risk Stratification for Second Primary Lung Cancer. J Clin Oncol. 2017;35:2893\u20132899. doi: 10.1200\/JCO.2017.72.4203"},{"key":"i-53-1-98-ref29","series-title":"PLOS ONE","first-page":"e0209002","article-title":"Incidence trends and risk prediction nomogram of metachronous second primary lung cancer in lung cancer survivors","volume":"13","author":"Hu","year":"2018","unstructured":"Hu ZG,\nLi WX,\nRuan YS,\nZheng FJ. Incidence trends and risk prediction nomogram of metachronous second primary lung cancer in lung cancer survivors. PLOS ONE. 2018;13:e0209002. doi: 10.1371\/journal.pone.0209002"},{"key":"i-53-1-98-ref30","series-title":"Lung Cancer","first-page":"183","article-title":"Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan","volume":"108","author":"Yang","year":"2017","unstructured":"Yang SC,\nLai WW,\nLin CC,\nSu WC,\nKu LJ,\nHwang JS, et al. Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan. Lung Cancer. 2017;108:183\u2013191. doi: 10.1016\/j.lungcan.2017.04.001"},{"key":"i-53-1-98-ref31","series-title":"JNCI J Natl Cancer Inst","first-page":"618","article-title":"The Survival Impact of Second Primary Lung Cancer in atients With Lung Cancer","volume":"114","author":"Choi","year":"2022","unstructured":"Choi EC,\nLuo SJ,\nAredo JV, et al. The Survival Impact of Second Primary Lung Cancer in atients With Lung Cancer. JNCI J Natl Cancer Inst. 2022;114:618\u2013625. doi: 10.1093\/jnci\/djab224"},{"key":"i-53-1-98-ref32","series-title":"OncoTargets and Therapy","first-page":"295","article-title":"Clinical outcomes of patients with metachronous second primary lung adenocarcinomas","volume":"10","author":"Zhao","year":"2017","unstructured":"Zhao H,\nYang H,\nHan K, et al. Clinical outcomes of patients with metachronous second primary lung adenocarcinomas. OncoTargets and Therapy. 2017;10:295\u2013302. doi: 10.2147\/OTT.S122908"},{"key":"i-53-1-98-ref33","article-title":"Latest Trends and Findings in Major Disease Incidence \u2013 China Re Life 202312","author":"Zhang","unstructured":"Zhang C,\nLi L,\nLiu X. Latest Trends and Findings in Major Disease Incidence \u2013 China Re Life 202312."},{"key":"i-53-1-98-ref34","series-title":"Gen Re. IFoA Asia Conference 2024","article-title":"Evolution of Critical Illness Insurance","author":"Li","unstructured":"Li O,\nTan R. Evolution of Critical Illness Insurance. An Experience-based Journey. Gen Re. IFoA Asia Conference 2024."},{"key":"i-53-1-98-ref01","series-title":"J Thorac Dis","first-page":"S526","article-title":"The new IASLC\/ATS\/ERS lung adenocarcinoma classification from a clinical perspective: current concepts and future prospects","volume":"6","author":"Zugazagoitia","year":"2014","unstructured":"Zugazagoitia J,\nEnguita AB,\nNu\u00f1ez JA,\nIglesias L,\nPonce S. The new IASLC\/ATS\/ERS lung adenocarcinoma classification from a clinical perspective: current concepts and future prospects. J Thorac Dis. 2014;6:S526\u2013S536. doi: 10.3978\/j.issn.2072-1439.2014.01.27"},{"key":"i-53-1-98-ref02","article-title":"Adenocarcinoma in situ, minimally invasive adenocarcinoma and invasive adenocarcinoma of lung","author":"Kusel","unstructured":"Kusel K. Adenocarcinoma in situ, minimally invasive adenocarcinoma and invasive adenocarcinoma of lung. Last revised on 8 Mar 2022. Radiology Reference Article | Radiopaedia.org."},{"key":"i-53-1-98-ref03","series-title":"Insights into Imaging","first-page":"69","article-title":"Adenocarcinoma of the lung: from BAC to the future","volume":"11","author":"Lambe","year":"2020","unstructured":"Lambe G,\nDurand M,\nBuckley A,\nNicholson S,\nMcDermott R. Adenocarcinoma of the lung: from BAC to the future. Insights into Imaging. 2020;11:69. doi: 10.1186\/s13244-020-00875-6"},{"key":"i-53-1-98-ref04","series-title":"J Thorac Oncol","first-page":"1204","article-title":"The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer","volume":"11","author":"Travis","year":"2016","unstructured":"Travis WD,\nAsamura H,\nBankier AA, et al. The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer. J Thorac Oncol. 2016;11:1204\u20131223."},{"key":"i-53-1-98-ref05","series-title":"J Clinical and Diagnostic Research","first-page":"EE01","article-title":"An Update on WHO Classification of Thoracic Tumours 2021- Newly Described Entities and Terminologies","volume":"17","author":"Singh","year":"2023","unstructured":"Singh G,\nSingh A,\nDAVE R. An Update on WHO Classification of Thoracic Tumours 2021- Newly Described Entities and Terminologies. J Clinical and Diagnostic Research. 2023;17:EE01\u2013EE05. doi: 10.7860\/JCDR\/2023\/62583.18076"},{"key":"i-53-1-98-ref06","series-title":"J National Cancer Center","first-page":"278","article-title":"The epidemiological landscape of lung cancer: current status, temporal trend and future projections based on the latest estimates from GLOBOCAN 2022","volume":"5","author":"Ji","year":"2025","unstructured":"Ji Y,\nZhang Y,\nLiu S, et al. The epidemiological landscape of lung cancer: current status, temporal trend and future projections based on the latest estimates from GLOBOCAN 2022. J National Cancer Center. 2025;5:278\u2013286."},{"key":"i-53-1-98-ref07","series-title":"The LANCET Respiratory Medicine","first-page":"348","article-title":"Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study","volume":"13","author":"Luo","year":"2025","unstructured":"Luo G,\nZhang Y,\nRumgay H, et al. Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study. The LANCET Respiratory Medicine. 2025;13:348\u2013363. doi: 10.1016\/S2213-2600(24)00428-4"},{"key":"i-53-1-98-ref08","series-title":"Frontiers in Oncology","first-page":"1059","article-title":"Epidemiology of Ground Glass Opacity Lung Adenocarcinoma: A Network-Based Cumulative Meta-Analysis","volume":"10","author":"Li","year":"2020","unstructured":"Li X,\nRen F,\nWang S, et al. Epidemiology of Ground Glass Opacity Lung Adenocarcinoma: A Network-Based Cumulative Meta-Analysis. Frontiers in Oncology. 2020;10:1059. doi: 10.3389\/fonc.2020.01059"},{"key":"i-53-1-98-ref09","series-title":"J Thorac Dis","first-page":"5383","article-title":"Discriminating invasive adenocarcinoma among lung pure ground-glass nodules: a multi-parameter prediction model","volume":"13","author":"Hu","year":"2021","unstructured":"Hu F,\nHuang H,\nJiang Y, et al. Discriminating invasive adenocarcinoma among lung pure ground-glass nodules: a multi-parameter prediction model. J Thorac Dis. 2021;13:5383\u20135394. doi: 10.21037\/jtd-21-786"},{"key":"i-53-1-98-ref10","series-title":"J Thorac Oncol","first-page":"77","article-title":"Screening for Lung Cancer, Overdiagnosis, and Healthcare Utilization: A Nationwide Population-Based Study","volume":"20","author":"Kim","year":"2025","unstructured":"Kim SY,\nSilvestri GA,\nKim YW, et al. Screening for Lung Cancer, Overdiagnosis, and Healthcare Utilization: A Nationwide Population-Based Study. J Thorac Oncol. 2025;20:77\u2013588. doi: 10.1016\/j.jtho.2024.12.006"},{"key":"i-53-1-98-ref11","series-title":"JAMA Internal Medicine","article-title":"Association of Computed Tomographic Screening Promotion With Lung Cancer Overdiagnosis Among Asian Women","author":"Gao","year":"2022","unstructured":"Gao W,\nWen CP,\nWu A,\nWelch HG. Association of Computed Tomographic Screening Promotion With Lung Cancer Overdiagnosis Among Asian Women. JAMA Internal Medicine. Published online January 18, 2022. doi: 10.1001\/jamainternmed.2021.7769"},{"key":"i-53-1-98-ref12","series-title":"Trans Lung Cancer Res","first-page":"452","article-title":"Lung cancer screening strategy for non-high-risk individuals: a narrative review","volume":"10","author":"Fu","year":"2021","unstructured":"Fu F,\nZhou Y,\nZhang Y,\nChen H. Lung cancer screening strategy for non-high-risk individuals: a narrative review. Trans Lung Cancer Res. 2021;10:452\u2013461. doi: 10.21037\/tlcr-20-943"},{"key":"i-53-1-98-ref13","series-title":"Chinese J Lung Cancer","first-page":"911","article-title":"Analysis of Clinical Epidemiological Characteristics of 15,967 Lung Cancer Surgery Patients in Yunnan Cancer Hospital from 2013 to 2022","volume":"27","author":"Tang","year":"2024","unstructured":"Tang R,\nLei Y,\nYe L, et al. Analysis of Clinical Epidemiological Characteristics of 15,967 Lung Cancer Surgery Patients in Yunnan Cancer Hospital from 2013 to 2022. Chinese J Lung Cancer. 2024;27:911. doi: 10.3779\/j.issn.1009-3419.2024.101.33"},{"key":"i-53-1-98-ref14","series-title":"Am J Respir Crit Care Med","first-page":"1208","article-title":"Recent trends in the identification of incidental pulmonary nodules","volume":"192","author":"Gould","year":"2015","unstructured":"Gould MK,\nTang T,\nLiu ILA, et al. Recent trends in the identification of incidental pulmonary nodules. Am J Respir Crit Care Med. 2015;192:1208. doi: 10.1164\/rccm.201505-0990OC"},{"key":"i-53-1-98-ref15","series-title":"European Radiology","first-page":"8279","article-title":"Trends in the incidence of pulmonary nodules in chest computed tomography","volume":"33","author":"Ward","year":"2023","unstructured":"Ward H,\nMatthieu R,\nNils H, et al. Trends in the incidence of pulmonary nodules in chest computed tomography. European Radiology. 2023;33:8279\u20138288. doi: 10.1007\/s00330-023-09826-3"},{"key":"i-53-1-98-ref16","series-title":"Scientific Reports","first-page":"13657","article-title":"Development and clinical application of deep learning model for lung nodules screening on CT images","volume":"10","author":"Gui","year":"2020","unstructured":"Gui S,\nMing S,\nLin Y, et al. Development and clinical application of deep learning model for lung nodules screening on CT images. Scientific Reports. 2020;10:13657. doi: 10.1038\/s41598-020-70629-3"},{"key":"i-53-1-98-ref17","series-title":"Respiration","first-page":"1024","article-title":"Incidental Pulmonary Nodules \u2013 What Do We Know in 2022","volume":"101","author":"Schmid-Bindert","year":"2022","unstructured":"Schmid-Bindert G,\nVogel-Claussen J,\nGutz S, et al. Incidental Pulmonary Nodules \u2013 What Do We Know in 2022. Respiration. 2022;101:1024\u20131034. doi: 10.1159\/000526818"},{"key":"i-53-1-98-ref18","series-title":"Cell Research","first-page":"649","article-title":"Treating lung cancer: defining surgical curative time window","volume":"33","author":"Fu","year":"2023","unstructured":"Fu F,\nChen Z,\nChen H. Treating lung cancer: defining surgical curative time window. Cell Research. 2023;33:649\u2013650. doi: 10.1038\/s41422-023-00852-w"},{"key":"i-53-1-98-ref19","series-title":"J Thorac Cardiovasc Surg","first-page":"456","article-title":"Surgery for pre- and minimally invasive lung adenocarcinoma","volume":"163","author":"Zhang","year":"2022","unstructured":"Zhang Y,\nMa X,\nShen X, et al. Surgery for pre- and minimally invasive lung adenocarcinoma. J Thorac Cardiovasc Surg. 2022;163:456\u2013464. doi: 10.1016\/j.jtcvs.2020.11.151"},{"key":"i-53-1-98-ref20","series-title":"J Thorac Cardiovasc Surg","first-page":"1614","article-title":"Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative","volume":"164","author":"Li","year":"2022","unstructured":"Li D,\nDeng C,\nWang S, et al. Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative. J Thorac Cardiovasc Surg. 2022;164:1614\u20131622. doi: 10.1016\/j.jtcvs.2022.06.017"},{"key":"i-53-1-98-ref21","series-title":"J Thorac Oncol","first-page":"1312","article-title":"Long-Term Prognosis of Patients with Resected Adenocarcinoma in situ and Minimally Invasive Adenocarcinoma of the Lung","volume":"16","author":"Yotsukura","year":"2021","unstructured":"Yotsukura M,\nAsamura H,\nMotoi N, et al. Long-Term Prognosis of Patients with Resected Adenocarcinoma in situ and Minimally Invasive Adenocarcinoma of the Lung. J Thorac Oncol. 2021;16:1312. doi: 10.1016\/j.jtho.2021.04.007. PMID: doi: 33915249"},{"key":"i-53-1-98-ref22","series-title":"J Thorac Cardiovasc Surg","first-page":"606","article-title":"Multiple primary lung cancers","volume":"70","author":"Martini","year":"1975","unstructured":"Martini N and Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70:606. PMID: doi: 170482"},{"key":"i-53-1-98-ref23","series-title":"Ann Thorac Surg","first-page":"863","article-title":"Second primary lung cancer","volume":"59","author":"Antakli","year":"1995","unstructured":"Antakli T,\nSchaefer RF,\nRutherford JE,\nRead RC. Second primary lung cancer. Ann Thorac Surg. 1995;59:863. doi: 10.1016\/0003-4975(95)00067-u. PMID: doi: 7695410"},{"key":"i-53-1-98-ref24","series-title":"J Thorac Oncol","first-page":"639","article-title":"The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification","volume":"11","author":"Detterbeck","year":"2016","unstructured":"Detterbeck FC,\nNicholson AG,\nFranklin WA, et al. The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification. J Thorac Oncol. 2016;11:639. doi: 10.1016\/j.jtho.2016.01.024. PMID: doi: 26940528"},{"key":"i-53-1-98-ref25","series-title":"Front Oncol","first-page":"1034752","article-title":"Multiple primary lung cancer: Updates of clinical management and genomic features","volume":"13","author":"Tian","year":"2023","unstructured":"Tian H,\nBai G,\nYang Z, et al. Multiple primary lung cancer: Updates of clinical management and genomic features. Front Oncol. 2023;13:1034752. doi: 10.33389\/fonc.2023.1034752. PMID: doi: 36910635"},{"key":"i-53-1-98-ref26","article-title":"Second Cancers After Lung Cancer","author":"The American Cancer Society medical and editorial content team","year":"2024","unstructured":"The American Cancer Society medical and editorial content team. Second Cancers After Lung Cancer. Last Revised: January 29, 2024. Cancer.org."},{"key":"i-53-1-98-ref27","series-title":"J Thorac Oncol","first-page":"1415","article-title":"Second Primary Lung Cancer \u2013 An Emerging Issue in Lung Cancer Survivors","volume":"19","author":"Jensen","year":"2024","unstructured":"Jensen S \u00d8,\nMoore DA,\nSurani AA,\nCrosbie PAJ,\nRosenfeld N,\nRintoul RC. Second Primary Lung Cancer \u2013 An Emerging Issue in Lung Cancer Survivors. J Thorac Oncol. 2024;19:1415\u20131426. doi: 10.1016\/j.jtho.2024.07.014"},{"key":"i-53-1-98-ref28","series-title":"J Clin Oncol","first-page":"2893","article-title":"Risk Stratification for Second Primary Lung Cancer","volume":"35","author":"Han","year":"2017","unstructured":"Han SS,\nRivera GA,\nTammemagi MC, et al. Risk Stratification for Second Primary Lung Cancer. J Clin Oncol. 2017;35:2893\u20132899. doi: 10.1200\/JCO.2017.72.4203"},{"key":"i-53-1-98-ref29","series-title":"PLOS ONE","first-page":"e0209002","article-title":"Incidence trends and risk prediction nomogram of metachronous second primary lung cancer in lung cancer survivors","volume":"13","author":"Hu","year":"2018","unstructured":"Hu ZG,\nLi WX,\nRuan YS,\nZheng FJ. Incidence trends and risk prediction nomogram of metachronous second primary lung cancer in lung cancer survivors. PLOS ONE. 2018;13:e0209002. doi: 10.1371\/journal.pone.0209002"},{"key":"i-53-1-98-ref30","series-title":"Lung Cancer","first-page":"183","article-title":"Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan","volume":"108","author":"Yang","year":"2017","unstructured":"Yang SC,\nLai WW,\nLin CC,\nSu WC,\nKu LJ,\nHwang JS, et al. Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan. Lung Cancer. 2017;108:183\u2013191. doi: 10.1016\/j.lungcan.2017.04.001"},{"key":"i-53-1-98-ref31","series-title":"JNCI J Natl Cancer Inst","first-page":"618","article-title":"The Survival Impact of Second Primary Lung Cancer in atients With Lung Cancer","volume":"114","author":"Choi","year":"2022","unstructured":"Choi EC,\nLuo SJ,\nAredo JV, et al. The Survival Impact of Second Primary Lung Cancer in atients With Lung Cancer. JNCI J Natl Cancer Inst. 2022;114:618\u2013625. doi: 10.1093\/jnci\/djab224"},{"key":"i-53-1-98-ref32","series-title":"OncoTargets and Therapy","first-page":"295","article-title":"Clinical outcomes of patients with metachronous second primary lung adenocarcinomas","volume":"10","author":"Zhao","year":"2017","unstructured":"Zhao H,\nYang H,\nHan K, et al. Clinical outcomes of patients with metachronous second primary lung adenocarcinomas. OncoTargets and Therapy. 2017;10:295\u2013302. doi: 10.2147\/OTT.S122908"},{"key":"i-53-1-98-ref33","article-title":"Latest Trends and Findings in Major Disease Incidence \u2013 China Re Life 202312","author":"Zhang","unstructured":"Zhang C,\nLi L,\nLiu X. Latest Trends and Findings in Major Disease Incidence \u2013 China Re Life 202312."},{"key":"i-53-1-98-ref34","series-title":"Gen Re. IFoA Asia Conference 2024","article-title":"Evolution of Critical Illness Insurance","author":"Li","unstructured":"Li O,\nTan R. Evolution of Critical Illness Insurance. An Experience-based Journey. Gen Re. IFoA Asia Conference 2024."}],"container-title":["Journal of Insurance Medicine"],"original-title":[],"link":[{"URL":"https:\/\/jim.kglmeridian.com\/view\/journals\/insm\/53\/1\/article-p98.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jim.kglmeridian.com\/downloadpdf\/journals\/insm\/53\/1\/article-p98.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jim.kglmeridian.com\/downloadpdf\/journals\/insm\/53\/1\/article-p98.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:46:55Z","timestamp":1771930015000},"score":1,"resource":{"primary":{"URL":"https:\/\/jim.kglmeridian.com\/view\/journals\/insm\/53\/1\/article-p98.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":68,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.17849\/insm-53-1-1-7.2","relation":{},"ISSN":["0743-6661"],"issn-type":[{"value":"0743-6661","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}